Routine Antiemetic Prophylaxis for Nonfasted Parturients Undergoing Cesarean Sections Under Spinal Anesthesia

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18+
SponsorSanliurfa Education and Research Hospital

About this trial

The aim of this prospective randomized double-blind study is to compare the effectiveness of routine antiemetic prophylaxis for the prevention of intraoperative nausea and vomiting (IONV) in non-fasted parturients undergoing emergency cesarean section under spinal anesthesia.

Nausea and vomiting are common complications during cesarean delivery performed under spinal anesthesia and may negatively affect maternal comfort and perioperative safety. The incidence of these symptoms may be particularly increased in emergency cesarean sections involving non-fasted (full-stomach) parturients. This study compares two commonly used antiemetic strategies, namely 5-hydroxytryptamine-3 (5-HT3) receptor antagonists and dopamine receptor antagonists, to determine their relative effectiveness in preventing IONV during surgery.

The findings are expected to contribute to optimization of antiemetic prophylaxis protocols, improvement of maternal comfort, and reduction of perioperative complications associated with nausea and vomiting during emergency cesarean delivery.

Eligibility criteria

Qualifiers

Pregnant women scheduled for emergency cesarean delivery under spinal anesthesia

Non-fasted (full-stomach) parturients

American Society of Anesthesiologists (ASA) physical status I-II

Age ≥ 18 years

Disqualifiers

ASA physical status III or higher

Refusal to participate

Elective cesarean delivery (non-emergency cases)

Preoperative antiemetic use within 24 hours before surgery

Trial design

Treatments tested in this trial

  • Ondansetron 4mg
  • metoclopramide

Treatment groups

100 Participants
are divided into 2 treatment groups